
OPKO Health OPK
€ 1.22
1.44%
Quartalsbericht 2026-Q1
hinzugefügt 28.04.2026
OPKO Health P/E 2011-2026 | OPK
P/E Jährlich OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 86.6 | -11.2 | -2.5 | -67.3 | 113 | -2.8 | -13.8 | -8.31 | -170 | -134 | -29.6 | -25.3 | -65.9 | -1.14 K |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 113 | -1.14 K | -105 |
P/E anderer Aktien in der Diagnostik & Forschung
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | ||
|
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
23.5 | $ 197.76 | -1.61 % | $ 22 B | ||
|
Celcuity
CELC
|
-30.3 | $ 88.05 | 0.84 % | $ 4.12 B | ||
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-0.125 | $ 3.33 | -13.28 % | $ 4.43 M | ||
|
Fulgent Genetics
FLGT
|
-8.7 | $ 17.7 | -1.61 % | $ 545 M | ||
|
Castle Biosciences
CSTL
|
-19.5 | $ 20.25 | -1.03 % | $ 587 M | ||
|
Aspira Women's Health
AWH
|
-0.101 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.0644 | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
-32.3 | $ 129.11 | 1.39 % | $ 16.2 B | ||
|
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
0.299 | $ 1.65 | 4.78 % | $ 7.3 M | ||
|
CareDx, Inc
CDNA
|
-46.5 | $ 23.48 | 0.99 % | $ 1.25 B | ||
|
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | ||
|
Illumina
ILMN
|
29.7 | $ 159.09 | -3.16 % | $ 24.7 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | ||
|
ICON Public Limited Company
ICLR
|
44.1 | $ 143.27 | -0.19 % | $ 11.2 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
0.606 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-18.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.498 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
27.2 | $ 17.75 | -3.9 % | $ 397 M | ||
|
Lantheus Holdings
LNTH
|
21.9 | $ 103.19 | -1.75 % | $ 6.96 B | ||
|
Natera
NTRA
|
-147 | $ 226.44 | 2.88 % | $ 31 B | ||
|
Charles River Laboratories International
CRL
|
-53.3 | $ 182.34 | -1.33 % | $ 9.04 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
-0.911 | $ 1.34 | -0.74 % | $ 402 M | ||
|
Medpace Holdings
MEDP
|
28.7 | $ 457.09 | -0.98 % | $ 13.2 B | ||
|
Mettler-Toledo International
MTD
|
32.7 | $ 1 129.53 | -1.91 % | $ 23.3 B | ||
|
Exact Sciences Corporation
EXAS
|
-93.8 | - | - | $ 19.8 B | ||
|
NeoGenomics
NEO
|
-13.7 | $ 10.38 | -1.05 % | $ 1.33 B | ||
|
Myriad Genetics
MYGN
|
-1.12 | $ 4.38 | 3.06 % | $ 406 M | ||
|
Personalis
PSNL
|
-5.3 | $ 9.75 | 0.62 % | $ 870 M | ||
|
Koninklijke Philips N.V.
PHG
|
33.8 | $ 26.24 | -2.09 % | $ 24.9 B | ||
|
Senseonics Holdings
SENS
|
-5.07 | $ 6.69 | -7.47 % | $ 279 M | ||
|
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
99.7 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-1.45 | $ 1.97 | 2.07 % | $ 4.53 M | ||
|
Twist Bioscience Corporation
TWST
|
-20.1 | $ 82.87 | -2.45 % | $ 4.96 B | ||
|
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 259.56 | -2.03 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
29.3 | $ 461.69 | -2.31 % | $ 174 B | ||
|
Trinity Biotech plc
TRIB
|
-6.21 | $ 0.58 | 1.74 % | $ 208 M | ||
|
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-0.933 | $ 8.93 | -4.08 % | $ 1.94 B | ||
|
Invitae Corporation
NVTA
|
-5.12 | - | - | $ 21.2 M |